Glutamate-Based Therapeutic Strategies for Schizophrenia: Emerging Approaches Beyond Dopamine. [PDF]
Int J Mol SciFadgyas-Stanculete M, Capatina OO.
europepmc +1 more source
Transcriptomic and Proteomic Changes in the Brain Along with Increasing Phenotypic Severity in a Rat Model of Neonatal Hyperbilirubinemia. [PDF]
Int J Mol SciLlido JP +11 more
europepmc +1 more source
Novel electroencephalographic biomarkers for the prediction of responders to an experimental glutamatergic agent in patients with schizophrenia. [PDF]
Transl PsychiatrySiekmeier PJ, Coyle JT.
europepmc +1 more source
Activation of Endoplasmic Reticulum-Localized Metabotropic Glutamate Receptor 5 (mGlu<sub>5</sub>) Triggers Calcium Release Distinct from Cell Surface Counterparts in Striatal Neurons. [PDF]
BiomoleculesJong YI, Harmon SK, O'Malley KL.
europepmc +1 more source
The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD. [PDF]
Int J Mol SciGrzesińska AD.
europepmc +1 more source
Innovative pharmacological depression treatment. [PDF]
Eur Arch Psychiatry Clin NeurosciMöller HJ, Rupprecht R, Reif A.
europepmc +1 more source
Parvalbumin interneurons mediate sex differences in prefrontal cortex function. [PDF]
NeuropsychopharmacologySeney ML, Joffe ME.
europepmc +1 more source
Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study. [PDF]
Alzheimers Res TherSalardini E +7 more
europepmc +1 more source
Glutamate-Mediated Neural Alterations in Lead Exposure: Mechanisms, Pathways, and Phenotypes. [PDF]
ToxicsTamagno WA, Freeman JL.
europepmc +1 more source
Neurotransmitters in tumors: chemical cross-talk shaping tumor progression. [PDF]
Biomark ResChen W +8 more
europepmc +1 more source